|
|||||
|
|
New and Worsening Long-term Immune-Related Adverse Events with PD-1/PD-L1 Pathway Agents in Patients with Cancer |
|
| Authors: | Kevin H. Hall Yuan Liu Chen Jiang R. Donald Harvey |
| Affiliation: | 1. Department of Pharmaceutical Services, Emory University Hospitals and Winship Cancer Institute, Atlanta, Georgia;2. Department of Biostatistics and Bioinformatics, Rollins School of Public Health of Emory University, Atlanta, Georgia;3. Departments of Hematology and Medical Oncology and Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia |
| Abstract: | |
| Keywords: | PD-1 PD-L1 immune checkpoint immune-related adverse events immunotherapy |